Citizens Reiterates OrthoPediatrics Corp. (KIDS) at Market Outperform

Citizens analyst David Turkaly reiterated a Market Outperform rating and $25.00 price target on OrthoPediatrics Corp. (NASDAQ: KIDS).

The analyst commented, "We reiterate our Market Outperform rating on OrthoPediatrics (KIDS) and $25 price target after the full release of 3Q25 operating results. Recall, on October 9, KIDS preannounced 3Q25 revenue of $61.2 mln (+12% y/y but ~4% below consensus) and lowered its sales guidance for FY25. Both the miss and guidance cut can be attributed to temporary issues, namely: 1) delayed 7D capital sales, and 2) headwinds in the Latin and South America (LATSAM) segment of business. After today's release and earnings call, we continue to believe KIDS's core business fundamentals, valuation, and forward cash flow metrics support our bullish long-term outlook."

For an analyst ratings summary and ratings history on OrthoPediatrics Corp. click here. For more ratings news on OrthoPediatrics Corp. click here.

Shares of OrthoPediatrics Corp. closed at $16.91 yesterday.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• FGI Industries Ltd (FGI) Tops Q2 EPS by 59c
• Marchex (MCHX) Reports In-Line Q2 EPS